» Articles » PMID: 26046703

The Safety and Predictability of Implanting Autologous Lenticule Obtained by SMILE for Hyperopia

Overview
Journal J Refract Surg
Date 2015 Jun 6
PMID 26046703
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the safety, effectiveness, stability, and predictability of implanting autologous lenticules obtained from small incision lenticule extraction for the treatment of hyperopia.

Methods: Five patients (10 eyes) with one myopic eye and one hyperopic eye were enrolled. The myopic eye was treated with small incision lenticule extraction; a lenticule was extracted and subsequently implanted in the hyperopic eye. Follow-up was at 1 day, 1, 3, 6, and 9 months, and 1 year postoperatively. Patients received a complete ophthalmologic examination at each visit, including uncorrected distance visual acuity, corrected distance visual acuity, anterior segment optical coherence tomography, and corneal topography.

Results: There were no complications in any eye during follow-up. Compared with preoperative levels, at the last follow-up visit the eyes with lenticule implantation showed mean spherical equivalent reduced by 5.53 diopters (residual spherical equivalent was +1.13 to -2.63 diopters), mean uncorrected distance visual acuity increased approximately two lines (approximately 20/63 to 20/40 Snellen), and corrected distance visual acuity in 4 (80%) eyes gained one line, 2 (40%) eyes gained two lines, and 1 (20%) eye gained more than two lines. There was no significant difference (P > .05) in spherical equivalent compared with 1 day postoperatively and the last follow-up visit. Corneal topography showed that the lenticule was uniform and located well; anterior segment optical coherence tomography images showed that the lenticule was transparent and the demarcation line was visible.

Conclusions: Implanting an autologous lenticule obtained by small incision lenticule extraction for hyperopia might be safe, effective, and stable, but its predictability should be improved in the future.

Citing Articles

Long-term follow-up of SMILE-derived corneal stromal lenticules preserved in nutrient capsules for treating corneal diseases.

Zhang Z, Yu Y, Sun B, Li M, Yao P, Wang X BMC Ophthalmol. 2025; 25(1):64.

PMID: 39930352 PMC: 11812144. DOI: 10.1186/s12886-025-03891-6.


Biochemical components of corneal stroma: a study on myopia classification based on Raman spectroscopy and deep learning methods.

Yu Z, Li Y, Xing T, Han M, Zhang Y, Gao J Biomed Opt Express. 2025; 16(1):28-41.

PMID: 39816144 PMC: 11729285. DOI: 10.1364/BOE.539721.


Long-term results of allogenic corneal lenticule of hyperopic SMILE for post-LASIK ectasia.

Li M, Wei R, Qin B, Chang J, Zhou X iScience. 2024; 27(9):110689.

PMID: 39280629 PMC: 11399612. DOI: 10.1016/j.isci.2024.110689.


Ex Vivo Lenticule Customization for Stromal Lenticule Addition Keratoplasty.

Nubile M, Alio Del Barrio J, Cerino L, Salgari N, El Zarif M, Totta M Invest Ophthalmol Vis Sci. 2024; 65(10):9.

PMID: 39102261 PMC: 11309033. DOI: 10.1167/iovs.65.10.9.


Lamellar surgeries with SMILE-derived lenticules.

Ganesh S, Brar S, Chopra R Taiwan J Ophthalmol. 2024; 14(1):70-77.

PMID: 38654992 PMC: 11034677. DOI: 10.4103/tjo.TJO-D-23-00171.